Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | THRA | P10827 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | PLA2G4B | P0C869 | 5/20 | 0.55 |
| ▸ | RARB | P10826 | 3/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.51 |
| ▸ | RELA | Q04206 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17059039 | 0.99 | HPGD (0.57) | HPGDTP53TSHRTHRATHRB | |
| SCHEMBL2451370 | 0.91 | HPGD (0.55) | HPGDTP53TSHRPLA2G4BRARB | |
| SCHEMBL10033674 | 0.91 | HPGD (0.55) | HPGDTP53TSHRPLA2G4BRARB | |
| SCHEMBL9591789 | 0.89 | HPGD (0.51) | HPGDTP53TSHRTHRATHRB | |
| SCHEMBL9591775 | 0.89 | HPGD (0.51) | HPGDTP53TSHRTHRATHRB | |
| SCHEMBL14016041 | 0.88 | TP53 (0.53) | TP53TSHRTHRATHRBPLA2G4B | |
| SCHEMBL9591784 | 0.87 | HPGD (0.49) | HPGDTP53TSHRTHRATHRB | |
| SCHEMBL5961805 | 0.86 | PARP10 (0.50) | HPGDNPC1LMNA | |
| SCHEMBL2020857 | 0.86 | TP53 (0.55) | TP53TSHRTHRATHRBPLA2G4B | |
| SCHEMBL9942262 | 0.86 | TP53 (0.55) | TP53TSHRTHRATHRBPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9500790-B2 | Optical film, circularly polarizing plate, and image display device | Konica Minolta, Inc. (JP) | 2016-11-22 | — | — | US | disclosed |
| US-20150247963-A1 | OPTICAL FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150247963-A1 | OPTICAL FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | SUN2, HTR3D, CRY1 | HPGD 2134/4885TP53 3261/4885TSHR 2612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.